<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang L</submitter><funding>Scientific Research Program of Tianjin Education Commission</funding><funding>Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital, Tianjin Key Laboratory of Metabolic Diseases</funding><funding>National Natural Science Foundation of China</funding><funding>Bethune Charitable Foundation</funding><funding>Hubei Chen Xiaoping Science and Technology Development Fund</funding><funding>China Endocrine Metabolism Talent Research Fund</funding><funding>Tianjin Key Medical Discipline (Specialty) Construction Project</funding><pagination>e187653</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11790033</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(2)</volume><pubmed_abstract>Diabetes mellitus (DM) is acknowledged as an independent risk factor for acute kidney injury. Ras guanine nucleotide-releasing protein-4 (RasGRP4) exerts a notable role in modulating immune-inflammatory responses and kidney disease progression in diabetes. Herein, we delved into the specific role and mechanism of RasGRP4 in diabetic renal ischemia-reperfusion injury. Diabetes was induced by a high-fat diet and streptozocin (STZ) injections, followed by creating an ischemia-reperfusion kidney injury via renal pedicle clamping and reperfusion. In vitro, a high glucose and hypoxia-reoxygenation modeled cellular inflammatory injury. We found RasGRP4-KO mice, compared with C57BL/6J (WT) mice, showed markedly less renal dysfunction and fibrosis in diabetic ischemia-reperfusion injury. There was </pubmed_abstract><journal>JCI insight</journal><pubmed_title>RasGRP4 aggravates ischemia-reperfusion injury in diabetic kidneys by mediating communication between macrophages and T cells.</pubmed_title><pmcid>PMC11790033</pmcid><funding_grant_id>2022-N-02-07,2023-N-03-15</funding_grant_id><funding_grant_id>ZXY-ZDSYSZD2022-1</funding_grant_id><funding_grant_id>Z04JKM2022E035</funding_grant_id><funding_grant_id>TJYXZDXK-032A</funding_grant_id><funding_grant_id>2022KJ248</funding_grant_id><funding_grant_id>CXPJJH122012-002</funding_grant_id><funding_grant_id>81600643</funding_grant_id><pubmed_authors>Yu P</pubmed_authors><pubmed_authors>Zhou S</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Meng X</pubmed_authors></additional><is_claimable>false</is_claimable><name>RasGRP4 aggravates ischemia-reperfusion injury in diabetic kidneys by mediating communication between macrophages and T cells.</name><description>Diabetes mellitus (DM) is acknowledged as an independent risk factor for acute kidney injury. Ras guanine nucleotide-releasing protein-4 (RasGRP4) exerts a notable role in modulating immune-inflammatory responses and kidney disease progression in diabetes. Herein, we delved into the specific role and mechanism of RasGRP4 in diabetic renal ischemia-reperfusion injury. Diabetes was induced by a high-fat diet and streptozocin (STZ) injections, followed by creating an ischemia-reperfusion kidney injury via renal pedicle clamping and reperfusion. In vitro, a high glucose and hypoxia-reoxygenation modeled cellular inflammatory injury. We found RasGRP4-KO mice, compared with C57BL/6J (WT) mice, showed markedly less renal dysfunction and fibrosis in diabetic ischemia-reperfusion injury. There was </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-19T16:24:19.041Z</modification><creation>2025-04-19T16:24:19.041Z</creation></dates><accession>S-EPMC11790033</accession><cross_references><pubmed>39656542</pubmed><doi>10.1172/jci.insight.187653</doi></cross_references></HashMap>